RxDoctor Payments Data

Grace Lee, MD

Anatomic Pathology & Clinical Pathology · Saint Louis, MONPI 1932151404

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Urogen Pharma, Inc. at 36.6% of the total. 2024 is the largest year on record at $253, 8.4 times the $30 reported in 2019.

$423in general payments, 2019–2025

Across 10 payments — averaging $42.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urogen Pharma, Inc.$155
  • Novo Nordisk$103
  • Roche Diagnostics Corporation$38
  • Incyte Corporation$23
  • Daiichi Sankyo Inc.$22
  • Merck$20
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$423100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$423 in reported general payments places this provider in the 85th percentile of 169 anatomic pathology & clinical pathology providers in Missouri.

See all anatomic pathology & clinical pathology providers in Missouri

Medicare billing

Part B allowed, 2024
$51,253
Medicare patients
716
Services billed
1,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →